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1. Introduction 
Wheat germ lectin (WGL) preferentially aggluti- 
nates transformed cells [1-4], although the underly- 
ing mechanism is not exactly known.This agglutina- 
tion can be inhibited by a glycolipid fraction derived 
from various tissues and cells, including human 
adenocarcinoma, Krebs ascites hepatoma, nd trans- 
formed BHK cells [4,5]. A glycoprotein with similar 
receptor activity was also isolated from Novikoff tu- 
mor cell surfaces [6]. The degree of inhibition ob- 
tained by glycolipid of transformed cells was higher 
than that of comparable normal cells, and a Smith- 
degraded glycolipid fraction of normal cells or tissue 
exhibited a much greater degree of reactivity than 
before degradation [4]. These findings are in accor- 
dance with the observation that Smith-degraded** 
Lewis glycolipids having GlcNAc at the non-reducing 
terminal showed an extremely high reactivity to WGL 
[7]. Carcinoembryonic antigen (CEA) of human di- 
gestive system, first described by Gold and Freedman 
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** Abbreviations: CEA, carcinoembryonic antigen of Dr. Phil 
Gold; this term is used according to his definition [6]; anti- 
CEA, antiserum directed against carcinoembryonic antigen 
of Gold; the antiserum showed amajor monospecific pre- 
cipitin line with CEA; Smith-degraded, product of Smith 
degradation [ 11 ], if applied to micelles of glycolipids with 
low concentration fperiodate, often resulting in degrada- 
tion of non-reducing terminals of carbohydrate chain [12 ]. 
[8] as a specific antigen for tumors of digestive or- 
gans and embryonic gastrointestinal tissue, has been 
identified as glycoprotein [9,10]. 
In this communication we wish to report a puri- 
fied glycosphingolipid showing strong reactivity to 
WGL as well as to anti-CEA antiserum. The glycolipid 
was isolated from human A erythrocytes and from 
human adenocarcinoma. A number of immunodif- 
fusion analyses indicated that the reactive sites for 
'anti-CEA' antiserum and those for 'WGL' are at least 
partially identical. 
2. Materials and methods 
Glycolipid fractions of tumor tissue [7] or of 
erythrocytes [ 13,14] were further fractionated by 
Folch's partition, followed by DEAE-cellulose chro- 
matography [15], according to the method for obtain- 
ing 'blood group glycolipids' described previously 
[14]. Each fraction was examined by gel diffusion 
analysis with WGL or with anti-CEA as follows: 
Glycolipid (100/ag) was dissolved in 100 gl of phys- 
iological saline on heating at 60-80°C and was placed 
in a 'cleaner bath' with sonicator for a few minutes. 
Twenty to thirty microlitres was put in a well of plas- 
tic template placed on 0.5% agarose in physiological 
saline and reacted with 10-20/al of a 1% solution (in 
physiological saline) of WGL or anti-CEA, according 
to the method of Sharpies and LoGrippo [ 16]. 
WGL was prepared according to Burger and 
Goldberg [2]; part of the preparation used in this ex- 
periment was purified by affinity chromatography 
[17] and was kindly donated by Dr. Nathan Sharon, 
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Volume 37, number 2 FEBS LETTERS December 1973 
Weizmann Institue of Science, Israel. Both prepara- 
tions showed an identical precipitin reaction with a 
specific glycolipid and glycoprotein. The precipitin re- 
action was enhanced in the presence of a trace amount 
of Ca 2÷ and Mn 2+ (10 -5 M) 
Anti-CEA was kindly donated by Dr. Phil Gold, 
Montreal General Hospital, and by Dr. Jack 
Haverback, University of Southern California. The 
fraction with positive reaction was further purified by 
this layer chromatography (TLC) on silica gel H and 
then acetylated in pyridine and acetic anhydride. The 
acetylated compounds were further separated on TLC 
as previously described according to the method ap- 
plied for extensive purification of H-glycolipid and 
other fucose glycolipids [ 18]. The purified glycolipids 
as acetate were deacetylated in chloroform-methanol-  
sodium methoxide [18] and analyzed. The carbohy- 
drate composition was analyzed according to the 
method described previously [6]. 
Glycoprotein with positive CEA reaction was pre- 
pared from human adenocarcinoma by the method of 
Gold et al. [8]. Purified CEA was a gift from Dr. Phil 
Gold and from Dr. Jack Haverback. NN'-diacetyl- 
chitobiose was a gift from Dr. T. Osawa, Tokyo Uni- 
versity, Faculty of Pharmaceutical Science. 
3. Results 
The purified glycosphingolipid obtained by acetyla- 
tion procedure gave a strong precipitin reaction with 
both WGL and with anti-CEA. This glycolipid inhibit- 
ed hemagglutination caused by WGL; 6-12/ag of 
glycolipid can i hibit hemagglutination caused by 
three hemagglutinating doses of WGL. Trials to sepa- 
rate components hat reacted with WGL from com- 
ponents that reacted with anti-CEA were all unsuccess- 
ful. Two samples of glycolipids prepared from human 
erythrocytes, two samples prepared from human 
adenocarcinoma (liver metastatic deposit from laryn- 
geal and cecal cancer), and four samples of CEA 
glycoprotein were all equally reactive to both WGL 
and anti-CEA. The two reactivities were demonstrated 
to be 'identical' or 'partially identical' according to 
the precipitin pattern on double diffusion agarose 
plates.* An example is shown in fig. 1A and lB. The 
precipitin line with WGL was completely suppressed 
by inclusion of 1 mM of NN'-diacetylchitobiose in 
A 
Fig. 1. Precipitin reaction in agar gel showing a shared reac- 
tivity between wheat germ lectin and anti-carcinoembryonic 
antigen: A, 1 WGL; 2 anti-CEA; 3 purified glycolipid 
hapten. B, 1 WGL; 2 anti-CEA; 3 purified CEAglyco- 
protein. 
agarose plates, in agreement with previous reports 
[2], whereas that with anti-CEA was only slightly 
suppressed even at 50 mM concentration of  NN'- 
diacetylchitobiose in agarose (experiment with anti- 
CEA provided by Dr. J. Haverback). This agreed with 
the previous observation that blood group hapten 
* A preliminary study with Dolichos biflorus and anti-A se- 
rum indicated that the Ouchterlony criterion [24] can be 
valid in interpreting the precipitin line formed by lectin and 
by immunoglobulin, although no extensive data are avail- 
able. The Ouchterlony criterion is also difficult to apply 
when a crude glycolipid antigen is used, as the pattern is 
greatly influenced by miceUar aggregation [ 25 ].The pattern 
shown in fig. 1 is produced by the purified glycolipid antigen. 
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inhibition was much more effective in reaction with 
lectin than with immunoglobulin, i.e. blood group A 
and H reactivities with various lectins were readily 
inhibited by immunodominant monosaccharide or 
oligosaccharide. The same reactivities with specific 
immunoglobulifis were more difficult to inhibit by 
monosaccharide or oligosaccharide [ 19]. The partici- 
pation of GlcNAc in determining CEA specificity 
was already suggested by Gold and his colleagues 
[21]. 
The purified glycolipid isolated from blood group 
A erythrocytes had fucose, glucose, galactose, glu- 
cosamine and galactosamine in the molar ratio of 1.0: 
0.9:2.1:0.9:1.7. Smith degradation caused destruction 
of fucose and galactosamine, but the reactivities to 
WGL and anti-CEA were intensified after degradation, 
suggesting that both activities reside on the internal 
structure of the carbohydrate chain, which is com- 
posed of N-acetylglucosamine (possibly 2 moles) and 
galactose. 
Purified glycolipid was obtained with an extremely 
poor yield (a few mg from 500 g of membrane prep- 
aration); further structural study is inconvenient at 
the present ime. The quantity of this glycolipid pre- 
sent in blood group A erythrocyte membrane was 
greater than that in blood group B or O erythrocytes, 
although quantitative data is not available at the pre- 
sent time. 
4. Comments 
The reactivities of glycolipid to WGL and to anti- 
CEA were not demonstrated when crude glycolipid 
fractions were tested; it was only possible after the 
glycolipid was freed from a large excess of contam- 
ination. This situation is the same as that for H-activ- 
ity of H-glycolipid, which was difficult to demon- 
strate with anti-H reagents (eel serum or Ulex euro- 
peus extract), unless it was purified [1 8]. The results 
of double diffusion assay indicated a strong possibil- 
ity that the reactive sites to anti-CEA also react to 
WGL. However, not all the structures that react to 
WGL are reactive to anti-CEA. A ceramide trisaccha- 
ride ( N-acetylglucosaminyl/~l-~3-galactosyl/31-~4-glu- 
cosylceramide) isolated from the degradation product 
of blood group glycolipid was strongly reactive to 
WGL but was devoid of~ny reactivity to anti-CEA. 
WGL must have a wide specificity that is directed to 
a number of structures made of/3-N-acetylglucosamine, 
whether they are located internal or external to the 
carbohydrate chain. Of a number of WGL reactive 
sites, only a few limited structures must be reactive to 
anti-CEA. The glycolipid isolated showed very similar 
properties on TLC as blood group glycolipids in Rf 
values on TLC and chemical composition. It is ex- 
tremely interesting to compare this data to that of 
Simmons and Pearlman, who recently described that 
CEA glycoprotein is essentially an 'incomplete blood 
group glycoprotein' [20]. 
The presence of a greater quantity of the glycolipid 
hapter~ in A erythrocytes than in B or O erythrocytes 
coincides with the observation that WGL reacts more 
strongly with blood group A substance than with B or 
O substances [5] and also with the observation that 
anti-A antibody combines with CEA giving some 
cross-reactivity between CEA and blood group sub- 
stance A [21 ]. These findings strongly suggest that 
synthesis of the structures which determine the reac- 
tivity to WGL or to anti-CEA can be controlled by 
regulatory genes that are functionally related to reg- 
ulation of A-gene expression. They could be located 
at close proximity to each other on the chromosome. 
It is interesting to note that expression of blood 
group A or B antigens closely relate to the develop- 
mental stages; they appear at the very early stage in 
primitive epithelial organs, disappear during develop- 
mental stages, and reappear after the developing or- 
gans reach their final adult form [23]; they disappear 
when transformed into tumor cells [5]. Their expres- 
sion is opposite to the behavior of CEA. 
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